CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT

Go back to CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
(NASDAQ: VTVT) Delayed: 33.26 +0.18 (0.54%)
Previous Close $33.08    52 Week High $7.70 
Open $33.19    52 Week Low $4.69 
Day High $33.85    P/E N/A 
Day Low $32.78    EPS $0.00 
Volume 26,675